Literature DB >> 21239251

Gene expression in cardiac hypertrophy.

K R Boheler1, K Schwartz.   

Abstract

Cardiac hypertrophy due to hemodynamic overload is a harbinger of morbidity and mortality in humans. The development of hypertrophy involves both quantitative and qualitative changes in gene expression that are thought to produce an enlarged organ more capable of meeting its new functional requirements. The genes are normal, but the way in which they are regulated is modified. Analysis of these changes and the mechanisms involved are essential if we are to understand the role that hypertrophy plays in the pathogenesis of heart failure.
Copyright © 1992. Published by Elsevier Inc.

Entities:  

Year:  1992        PMID: 21239251     DOI: 10.1016/1050-1738(92)90046-U

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  4 in total

1.  Sildenafil augments early protective transcriptional changes after ischemia in mouse myocardium.

Authors:  Ramesh Vidavalur; Suresh Varma Penumathsa; Mahesh Thirunavukkarasu; Lijun Zhan; Winfried Krueger; Nilanjana Maulik
Journal:  Gene       Date:  2008-10-25       Impact factor: 3.688

2.  Hypertrophic cardiomyopathy: a desensitized cardiac beta-adrenergic system in the presence of normal plasma catecholamine concentrations.

Authors:  C Schumacher; H Becker; R Conrads; U Schotten; S Pott; M Kellinghaus; M Sigmund; F Schöndube; C Preusse; H D Schulte
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

3.  DNA methylation regulates mouse cardiac myofibril gene expression during heart development.

Authors:  Yang Xu; Lingjuan Liu; Bo Pan; Jing Zhu; Changlong Nan; Xupei Huang; Jie Tian
Journal:  J Biomed Sci       Date:  2015-10-17       Impact factor: 8.410

4.  Phenylephrine, endothelin, prostaglandin F2alpha' and leukemia inhibitory factor induce different cardiac hypertrophy phenotypes in vitro.

Authors:  K L King; J Winer; D M Phillips; J Quach; P M Williams; J P Mather
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.925

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.